UModerna, umemezele namuhla ukuthi uMnyango Wezokudla Nezidakamizwa Ezokuphepha eKorea (MFDS) ukhiphe isigunyazo sokumaketha i-Spikevax®, umuthi wokugomela i-Moderna we-COVID-19 (mRNA-1273) okhiqizwe ngabakwaSamsung Biologics, iCDMO ehamba phambili emhlabeni wonke ehlinzeka ngesiphetho esididiyelwe ngokuphelele. ukuqeda ukuthuthukiswa kwenkontileka kanye nezinsiza zokukhiqiza.
Lesi sigunyazo sokumaketha esitholwe yiModerna Korea sivumela ngokusemthethweni umuthi wokugomela weModerna we-COVID-19 okhiqizwe ezindaweni zokukhiqiza imithi yasendaweni yakwaSamsung Biologics ukuthi usatshalaliswe ngaphakathi kweKorea futhi uthunyelwe kwamanye amazwe.
IModerna Korea yafaka isicelo sokugunyazwa ngokugcwele ukumaketha i-Spikevax® ne-MFDS ekuqaleni kukaNovemba futhi yayithola ngempumelelo phakathi nesikhathi esiyinyanga.
IPhilippines neColombia igunyaze ukusetshenziswa okuphuthumayo komgomo weModerna COVID-19 okhiqizwe ngabakwaSamsung Biologics ngoNovemba 26 nangoDisemba 2, ngokulandelana.
“Sibonga uMnyango Wezokudla Nezokuphepha Kwezidakamizwa waseKorea ngesinqumo sabo sokugunyaza lesi sigunyazo sokumaketha. Ukubambisana kwethu nabakwaSamsung Biologics ekwenzeni umgomo wokugomela i-Moderna COVID-19 kusisiza ukuthi siqhubeke nokukhulisa amandla ethu okukhiqiza ngaphandle kwase-US,” kusho uStéphane Bancel, oyiChief Executive Officer yakwaModerna. "Sikanye nabalingani bethu kwezokukhiqiza, sisazibophezele ekunqobeni ubhubhane lwe-COVID-19."
"Lesi yingqopha-mlando ebalulekile njengoba sikwazile ukusheshisa inqubo yokugunyazwa ngokubambisana ngokushesha nangokushesha nohulumeni waseKorea kanye neModerna, ikakhulukazi ngaphansi kokuhlolwa okuqinile kwe-MFDS kokukhiqizwa kokugoma kokuqala kwemithi yokugomela i-mRNA eKorea," kusho uJohn. Rim, i-CEO ye-Samsung Biologics. "Siphinde saziqhenya ngokubonisa ukuzibophezela kwethu ekuhlinzekeni kokubili ikhwalithi nokusebenza kwayo phakathi nezinqubo zethu, futhi sizoqhubeka nokusebenzisana eduze neklayenti lethu ukuze sinikeze imikhiqizo ngokuzinzile ikakhulukazi ngenxa yokubaluleka okwandayo kanye nesidingo semithi yokugoma empini yokulwa ne-COVID. - Ubhubhane lwe-19. "
IModerna inabalingani abaningi abanamasu okukhiqiza ukuqeda. E-US, lokhu kuhlanganisa Inkampani Catalent, Inc. (NYSE: CTLT), Baxter BioPharma Solutions futhi Sanofi (Nasdaq: SNY). Ngaphandle kwe-US, lokhu kuhlanganisa I-Rovi (BME: ROVI) eSpain, I-Recipharm eFrance futhi I-Samsung Biologics (KRX: 207940.KS) e-Korea.
Mayelana neModerna
Eminyakeni eyi-10 selokhu yasungulwa, iModerna isishintshile isuka ekubeni inkampani yesigaba socwaningo lwesayensi ethuthukisa izinhlelo emkhakheni we-messenger RNA (mRNA), yaba yibhizinisi elinephothifoliyo emitholampilo ehlukahlukene yemithi yokugoma nokwelashwa ngezindlela eziyisikhombisa, iphothifoliyo ebanzi yempahla yengqondo. ezindaweni ezihlanganisa ukwakhiwa kwe-mRNA kanye ne-lipid nanoparticle, kanye nemboni yokukhiqiza edidiyelwe evumela kokubili ukukhiqizwa komtholampilo nokuhweba ngezinga elilinganiselwe nangesivinini esingakaze sibonwe. IModerna igcina imifelandawonye nohlu olubanzi lohulumeni basekhaya nabaphesheya kwezilwandle nabahlanganyeli bezentengiselwano, okuvumele ukuphishekela kokubili isayensi ephula umthetho kanye nokukalwa ngokushesha kokukhiqiza. Muva nje, amakhono kaModerna ahlangene ukuze avumele ukusetshenziswa okugunyaziwe komunye wemithi yokugomela yokuqala nesebenza ngempumelelo yokulwa nobhubhane lwe-COVID-19.
Ipulatifomu ye-mRNA yeModerna yakhela entuthukweni eqhubekayo kusayensi eyisisekelo nesetshenziswayo ye-mRNA, ubuchwepheshe bokulethwa kanye nokukhiqiza, futhi ivumele ukuthuthukiswa kwemithi yokwelapha neyokugomela izifo ezithathelwanayo, i-immuno-oncology, izifo ezingavamile, izifo zenhliziyo nemithambo yegazi kanye nezifo ezivikela umzimba ngokuzenzakalelayo. UModerna uqokwe njengomqashi ophambili we-biopharmaceutical ngu Isayensi iminyaka eyisikhombisa edlule. Ukuze ufunde kabanzi, vakashela www.ktourcom.ru.
Mayelana ne-Samsung Biologics Co., Ltd.
I-Samsung Biologics (KRX: 207940.KS) iyi-CDMO ehlanganiswe ngokugcwele enikeza ukuthuthukiswa kwenkontileka yesimanje, ukukhiqiza, kanye nezinsizakalo zokuhlola ilabhorethri. Ngokugunyazwa okuqinisekisiwe kokulawula, umthamo omkhulu kakhulu, kanye nokusebenza okushesha kakhulu, i-Samsung Biologics inguzakwethu ozikhethele wona futhi ikwazi ngokukhethekile ukusekela ukuthuthukiswa nokukhiqizwa kwemikhiqizo ye-biologics kuzo zonke izigaba zenqubo kuyilapho ihlangabezana nezidingo eziguqukayo ze-biopharmaceutical. izinkampani emhlabeni jikelele. Ukuze uthole ulwazi olwengeziwe, vakashela www.samsungbiologicals.com.
